Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HNRNPA2/B1 is upregulated in endocrine-resistant LCC9 breast cancer cells and alters the miRNA transcriptome when overexpressed in MCF-7 cells
Carolyn M. Klinge, Kellianne M. Piell, Christine Schaner Tooley, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

The interplay between m6A RNA methylation and noncoding RNA in cancer
Shuai Ma, Chen Chen, Xiang Ji, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 503
Interaction between N6-methyladenosine (m6A) modification and noncoding RNAs in cancer
Yi Chen, Lin Yu, Yongqian Shu, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 220
Role of non-coding RNAs and RNA modifiers in cancer therapy resistance
Xinyi Zhang, Kai Xie, Honghua Zhou, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 204
RNA packaging into extracellular vesicles: An orchestra of RNA‐binding proteins?
Fabrizio Fabbiano, Jessica Corsi, Elena Gurrieri, et al.
Journal of Extracellular Vesicles (2020) Vol. 10, Iss. 2
Open Access | Times Cited: 199
Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
You-Cai Yi, Xiaoyu Chen, Jing Zhang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 191
Insights into N6-methyladenosine and programmed cell death in cancer
Li Liu, Hui Li, Dingyu Hu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 172
mRNA modifications in cardiovascular biology and disease: with a focus on m6A modification
Rajesh Kumari, Prabhat Ranjan, Zainab Suleiman, et al.
Cardiovascular Research (2021) Vol. 118, Iss. 7, pp. 1680-1692
Open Access | Times Cited: 138
Small RNA modifications: regulatory molecules and potential applications
Qunli Xiong, Yaguang Zhang
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 48
RNA methylations in human cancers
Xiao Han, Mengke Wang, Yongliang Zhao, et al.
Seminars in Cancer Biology (2020) Vol. 75, pp. 97-115
Closed Access | Times Cited: 133
Regulation of breast cancer metastasis signaling by miRNAs
Belinda J. Petri, Carolyn M. Klinge
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 3, pp. 837-886
Open Access | Times Cited: 113
Interactions between m6A modification and miRNAs in malignant tumors
Xiao Han, Jing Guo, Zhipeng Fan
Cell Death and Disease (2021) Vol. 12, Iss. 6
Open Access | Times Cited: 81
The role of miRNA biogenesis and DDX17 in tumorigenesis and cancer stemness
Kou‐Juey Wu
Biomedical Journal (2020) Vol. 43, Iss. 2, pp. 107-114
Open Access | Times Cited: 72
Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers
Dawei Rong, Guangshun Sun, Fan Wu, et al.
Molecular Therapy — Nucleic Acids (2021) Vol. 25, pp. 67-82
Open Access | Times Cited: 69
Effects of writers, erasers and readers within miRNA‐related m6A modification in cancers
Huiru Feng, Xiaofei Yuan, Shuting Wu, et al.
Cell Proliferation (2022) Vol. 56, Iss. 1
Open Access | Times Cited: 39
HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis
Ke Li, Quan Gong, Xudong Xiang, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 33
Small molecule inhibitors targeting m6A regulators
Guotai Feng, Yongya Wu, Yuan Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 12
Exploring m6A modifications in gastric cancer: from molecular mechanisms to clinical applications
Penghui Li, Xiangjie Fang, Di Huang
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Regulation of Gene Expression Associated With the N6-Methyladenosine (m6A) Enzyme System and Its Significance in Cancer
Shuoran Tian, Junzhong Lai, Tingting Yu, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 44
Epigenetic regulations in mammalian spermatogenesis: RNA-m6A modification and beyond
Yiqian Gui, Shuiqiao Yuan
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4893-4905
Closed Access | Times Cited: 44
HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells
Belinda J. Petri, Kellianne M. Piell, Gordon C. South Whitt, et al.
Cancer Letters (2021) Vol. 518, pp. 152-168
Open Access | Times Cited: 41
Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets
Ya Lu, Xinyue Wang, Quan Gu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 37
m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer
Belinda J. Petri, Carolyn M. Klinge
Journal of Molecular Endocrinology (2022) Vol. 70, Iss. 2
Open Access | Times Cited: 32
Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer
Pourya Sarvari, Pouya Sarvari, Ivonne Ramírez‐Díaz, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9521-9521
Open Access | Times Cited: 30
Emerging Mutual Regulatory Roles between m6A Modification and microRNAs
Zongqin Mei, Yahao Mou, Nan Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 773-773
Open Access | Times Cited: 16
Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics
Yinghuan Cen, Letian Chen, Zihao Liu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top